New York, NY -- (SBWIRE) -- 12/30/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Rexahn Pharmaceuticals, Inc.(NYSEMKT:RNN)Gerdau SA (ADR)(NYSE:GGB), Gevo, Inc.(NASDAQ:GEVO), Newcastle Investment Corp.(NYSE:NCT)
Rexahn Pharmaceuticals, Inc.(NYSEMKT:RNN) settled 3.32% higherat $0.517on above-normal volume of 3.06M shares during the last trading day. The stock has its 12-month high at $0.66 and 52-week low price was $0.28. It traded in a range of $0.49 to $0.53 during the last trading day.Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for cancer, central nervous system disorders, sexual dysfunction, and other medical needs.
Can Investors Bet on RNN after this News update? Find out in this Research Report
In the last trading session, Gerdau SA (ADR)(NYSE:GGB) was up on low volume, trading at a volume of 3.11 million versus its average daily volume of 4.55million shares. At $7.93, the stock has attained market capitalization of $13.49billion whereas its outstanding shares are 1.70million.Gerdau S.A. engages in the production and commercialization of steel products worldwide.
How Should Investors Trade GGB Now? Don’t Miss out a Special Trend Analysis
Gevo, Inc.(NASDAQ:GEVO) managed to keep its gain at 3.73% on above-normal volume of 3.04M shares. The stock settled at $1.39 after floating in a range of $1.30to $1.42. At its latest price, the stock reached market capitalization of $65.59 million. Its 52-week range has been $1.12to $2.75.
How Should Investors Trade GEVO Now? Don’t Miss out a Special Trend Analysis
Newcastle Investment Corp.(NYSE:NCT)) traded down on a volume of 2.95 million, lower than its standard daily volume. Shares have dropped1.05% to $5.68. Over the last twelve months, the stock has gained 618.99% and faced a worst price of $4.70.
Is NCT a Solid Investment at These Levels? Read This Report For Details
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)